Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2018 | Story UFS | Photo Rulanzen Martin
Prof Charles Ngwena is a former professor in the UFS Department
Prof Charles Ngwena is a former professor in the UFS Department of Constitutional Law and Legal Philosophy in the Faculty of Law.

The meaning of race, culture and sexism in Africa takes a different tone than it does in the West. The West has always tried to create an identity for Africa, but the real question remains: “What does it mean to be an African?’ 

“My aim with this book was to see how discourse is formed and what it means when you say the word ‘African’, which is meaningless. You have to look back to understand how that was created,” said Prof Charles Ngwena.

Prof Ngwena’s new book, asks the critical question,‘What is Africanness?’ Fully titled, What is Africanness? Contesting nativism in race, culture and sexualities is a timely contribution to contemporary South African debates on issues of decolonisation, race, ethnicity, nation building and belonging.

Identity formation a crucial element

“The book speaks directly to African cultural heritage and deconstructs a Western-imposed and homogenising framework for understanding Africanness,” said Dr Nadine Lake from the Centre for Gender and Africa Studies (CGAS) at the University of the Free State (UFS).

Prof Ngwena foregrounds the importance of intersectionality when approaching issues of race, culture and sexuality and writes: “Genericness is ineluctably homogenising. It can serve to obscure heterogeneities among women, pre-empting the need to explore the implications of differences among women in feminist theory and praxis.

“Identity is being and becoming. It is always changing. What young people think of identity is not the same way their grandparents thought about it,” said Prof Ngwena. He added that his contribution through this book was to underlay identity formation.

The book, published by Pretoria University Law Press (PULP), was launched in a joint venture by CGAS, the Centre for Human Rights at the University of Pretoria on Tuesday 11 September 2018 at the UFS.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept